These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of chemotherapy on antibody levels directed against PGL-I and 85A and 85B protein antigens in lepromatous patients. Drowart A, Chanteau S, Huygen K, De Cock M, Cartel JL, De Bruyn J, Launois P, Yernault JC, Van Vooren JP. Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):29-34. PubMed ID: 8326178 [Abstract] [Full Text] [Related]
8. Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens. Cho SN, Cellona RV, Fajardo TT, Abalos RM, dela Cruz EC, Walsh GP, Kim JD, Brennan PJ. Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):25-31. PubMed ID: 2030314 [Abstract] [Full Text] [Related]
9. Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions. Silva EA, Iyer A, Ura S, Lauris JR, Naafs B, Das PK, Vilani-Moreno F. Trop Med Int Health; 2007 Dec; 12(12):1450-8. PubMed ID: 18076551 [Abstract] [Full Text] [Related]
10. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT). Rada E, Ulrich M, Aranzazu N, Rodriguez V, Centeno M, Gonzalez I, Santaella C, Rodriguez M, Convit J. Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484 [Abstract] [Full Text] [Related]
11. Antibodies to phenolic glycolipid-I during long-term therapy: serial measurements in individual patients. Miller RA, Gorder D, Harnisch JP. Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):633-6. PubMed ID: 3323367 [Abstract] [Full Text] [Related]
12. Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients. Andreoli A, Brett SJ, Draper P, Payne SN, Rook GA. Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):211-7. PubMed ID: 3894538 [Abstract] [Full Text] [Related]
13. Serological monitoring of the response to chemotherapy in leprosy patients. Roche PW, Britton WJ, Failbus SS, Neupane KD, Theuvenet WJ. Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):35-43. PubMed ID: 8326179 [Abstract] [Full Text] [Related]
14. Use of a different buffer system in the phenolic glycolipid-I ELISA. Sticht-Groh V, Alvarenga AE, Vettom L, von Ballestrem W. Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):570-4. PubMed ID: 1299712 [Abstract] [Full Text] [Related]
15. Mycobacterium leprae particle agglutination in diagnosis and monitoring of treatment of leprosy. Kampirapap K. J Med Assoc Thai; 1999 Oct; 82(10):1020-4. PubMed ID: 10561966 [Abstract] [Full Text] [Related]
17. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia. Desforges S, Bobin P, Brethes B, Huerre M, Moreau JP, Bach MA. Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462 [Abstract] [Full Text] [Related]